Human Umbilical Cord Mesenchymal Stem Cells in Metabolic Dysfunction-associated Fatty Liver Disease (MAFLD) Therapy: Mechanisms, Clinical Efficacy, and Future Perspectives.

Jiang H, Wang H, Zhu Y, Yi C, Liu J, Zhao R, Gao J, Cao A, Guo Y

Open source

DOI
10.1007/s12015-026-11181-x
Published
2026 Oct
Container
Stem cell reviews and reports
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1007/s12015-026-11181-x,
  title = {Human Umbilical Cord Mesenchymal Stem Cells in Metabolic Dysfunction-associated Fatty Liver Disease (MAFLD) Therapy: Mechanisms, Clinical Efficacy, and Future Perspectives.},
  author = {Jiang H and Wang H and Zhu Y and Yi C and Liu J and Zhao R and Gao J and Cao A and Guo Y},
  year = {2026},
  journal = {Stem cell reviews and reports},
  doi = {10.1007/s12015-026-11181-x},
  url = {https://doi.org/10.1007/s12015-026-11181-x}
}

RIS

TY  - JOUR
TI  - Human Umbilical Cord Mesenchymal Stem Cells in Metabolic Dysfunction-associated Fatty Liver Disease (MAFLD) Therapy: Mechanisms, Clinical Efficacy, and Future Perspectives.
AU  - Jiang H
AU  - Wang H
AU  - Zhu Y
AU  - Yi C
AU  - Liu J
AU  - Zhao R
AU  - Gao J
AU  - Cao A
AU  - Guo Y
PY  - 2026
JO  - Stem cell reviews and reports
DO  - 10.1007/s12015-026-11181-x
UR  - https://doi.org/10.1007/s12015-026-11181-x
ER  - 

APA

H, J., H, W., Y, Z., C, Y., J, L., R, Z., J, G., A, C., & Y, G. (2026). Human Umbilical Cord Mesenchymal Stem Cells in Metabolic Dysfunction-associated Fatty Liver Disease (MAFLD) Therapy: Mechanisms, Clinical Efficacy, and Future Perspectives.. Stem cell reviews and reports. https://doi.org/10.1007/s12015-026-11181-x

Source records